The prognostic value of the tumour-stroma ratio validates in subgroups of breast cancer, especially in grade III tumours

被引：0
|
作者：
Mesker, W. [1 ]
Vangangelt, K.
Green, A. [2 ]
Heemskerk, I.
Cohen, D.
Putter, H.
Rakha, E. [2 ]
Tollenaar, R.
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Nottingham, Nottingham, England
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-04-003
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Tumour-stroma ratio: a strong and independent prognostic factor for adenocarcinomas of the esophagus
    Wouters, M.
    Takkenberg, M.
    Mesker, W.
    Smit, V.
    Stassen, L.
    Hartgrink, H.
    Tollenaar, R.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 57 - 57
  • [22] Prognostic significance of tumour stroma ratio in inflammatory breast cancer
    Downey, Candice L.
    Thygesen, Helene H.
    Sharma, Nisha
    Shaaban, Abeer M.
    SPRINGERPLUS, 2015, 4
  • [23] Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients’
    C L Downey
    S A Simpkins
    D L Holliday
    J L Jones
    L B Jordan
    J Kulka
    A M Hanby
    V Speirs
    British Journal of Cancer, 2015, 112 : 1833 - 1834
  • [24] Improving Objective Measurements of the Tumour-Stroma Ratio in Breast Cancer Using Polarized Light Microscopy
    Sprenger, Jillian
    Murray, Ciara
    Lad, Jigar
    Jones, Blake
    Thomas, Georgia
    Nofech-Mozes, Sharon
    Khorasani, Mohammadali
    Vitkin, Alex
    ADVANCES IN MICROSCOPIC IMAGING III, 2021, 11922
  • [25] The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer
    Vangangelt, Kiki M. H.
    Green, Andrew R.
    Heemskerk, Isabelle M. F.
    Cohen, Danielle
    van Pelt, Gabi W.
    Sobral-Leite, Marcelo
    Schmidt, Marjanka K.
    Putter, Hein
    Rakha, Emad A.
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (08) : 2296 - 2304
  • [26] Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'
    Downey, C. L.
    Simpkins, S. A.
    Holliday, D. L.
    Jones, J. L.
    Jordan, L. B.
    Kulka, J.
    Hanby, A. M.
    Speirs, V.
    BRITISH JOURNAL OF CANCER, 2015, 112 (11) : 1833 - 1834
  • [27] Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer
    Zunder, Stephanie M.
    Perez-Lopez, Raquel
    de Kok, Bente M.
    Vittoria Raciti, Maria
    van Pelt, Gabi W.
    Dienstmann, Rodrigo
    Garcia-Ruiz, Alonso
    Meijer, C. Arnoud
    Gelderblom, Hans
    Tollenaar, Rob A.
    Nuciforo, Paolo
    Wasser, Martin N.
    Mesker, Wilma E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 133
  • [28] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Marloes A. Smit
    Gabi W. van Pelt
    Valeska Terpstra
    Hein Putter
    Rob A. E. M. Tollenaar
    Wilma E. Mesker
    J. Han J. M. van Krieken
    International Journal of Colorectal Disease, 2021, 36 : 2729 - 2737
  • [29] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Smit, Marloes A.
    van Pelt, Gabi W.
    Terpstra, Valeska
    Putter, Hein
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    van Krieken, J. Han J. M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (12) : 2729 - 2737
  • [30] Prognostic value of CD8 Immunogradient indicators in tumour-stroma interface zone of colorectal cancer
    Nestarenkaite, A.
    Rasmusson, A.
    Zilenaite, D.
    Augulis, R.
    Laurinaviciene, A.
    Ostapenko, V.
    Poskus, T.
    Laurinavicius, A.
    VIRCHOWS ARCHIV, 2019, 475 : S206 - S207
12345